These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 208124)

  • 21. Proceedings: Cyclic AMP: cell-to-cell movement and inotropic effect in ventricular muscle, studied by a cut-end method.
    Tsien RW; Weingart R
    J Physiol; 1974 Oct; 242(2):95P-96P. PubMed ID: 4376174
    [No Abstract]   [Full Text] [Related]  

  • 22. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T; Oka M; Noda K; Ukai Y
    Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Method for initial evaluation of the action of antiinflammatory agents in rheumatoid arthritis].
    Bonollo L; Acocella G; Manzini A; Marchetti M; Nicolis FB
    Boll Chim Farm; 1972 Jan; 111(1):35-46. PubMed ID: 4555648
    [No Abstract]   [Full Text] [Related]  

  • 24. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
    Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T
    Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the antiallergic drug disodium cromoglycate on phosphodiesterase activity.
    Ochoa de Aspuru E; Zatón AM
    J Enzyme Inhib; 1996; 10(2):135-9. PubMed ID: 8835938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some new aspects of the pharmacotherapy of rheumatoid arthritis.
    Munthe E
    Scand J Rheumatol Suppl; 1980; 38():35-43. PubMed ID: 6259720
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic nucleotides in lymphocyte function.
    Hadden JW
    Ann N Y Acad Sci; 1975 Jun; 256():352-64. PubMed ID: 169723
    [No Abstract]   [Full Text] [Related]  

  • 30. 3-Substituted 5,7-dimethylpyrazolo(1,5-a)pyrimidines, 3',5'-cyclic-AMP phosphodiesterase inhibitors. 1.
    Novinson T; Hanson R; Dimmitt MK; Simon LN; Robins RK; O'Brien DE
    J Med Chem; 1974 Jun; 17(6):645-8. PubMed ID: 4364336
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiinflammatory compounds exhibiting fibrinolytic activity.
    Roubal Z; Nĕmecek O
    J Med Chem; 1966 Nov; 9(6):840-2. PubMed ID: 5972042
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipoidal anti-inflammatory prodrugs as local targeting agents.
    Bilski AJ; Evans JR; Harrison MP; Jones G; Marten TR; Milburn GT; Thomson DS; White DF
    Biochem Soc Trans; 1986 Apr; 14(2):388-91. PubMed ID: 3011550
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG.
    Lehmeyer JE; Johnston RB
    Clin Immunol Immunopathol; 1978 Apr; 9(4):482-90. PubMed ID: 206400
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.
    Silvola J; Kangasaho M; Tokola O; Vapaatalo H
    Agents Actions; 1982 Oct; 12(4):516-20. PubMed ID: 6295110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 3',5'-cyclic AMP phosphodiesterase with anti-inflammatory agents.
    Stefanovich V
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):573-82. PubMed ID: 4363357
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of 3',5'-cyclic AMP phosphodiesterase by acid mucopolysaccharides and sulfopolysaccharides.
    Stefanovich V
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):557-72. PubMed ID: 4363356
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
    Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
    Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulators of cyclic AMP systems.
    Hess SM; Chasin M; Free CA; Harris DN
    Adv Biochem Psychopharmacol; 1975; (14):153-67. PubMed ID: 242200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of correlation between antiinflammatory activity and inhibition of 3',5'-Cyclic AMP phosphodiesterase activity in a series of antiinflammatory agents.
    García-Rafanell J; Sánchez MS; Rimbau V; Forn J
    Rev Esp Fisiol; 1978 Mar; 34(1):55-9. PubMed ID: 208124
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.